Scientific Letter
Assessment of plasma endocan for the prediction of mortality in COVID-19 patients undergoing veno-venous ECMO: A pilot study
Evaluación del endocan para la predicción de la mortalidad en pacientes COVID-19 sometidos a ECMO veno-venosa: un estudio piloto
C. Levya,b,c,e, N. Dognona,b,c,e, S. Normandina,b,c,e, T. Duburcqa,b,c,e, A. Gaudeta,b,c,d,e,
, Lille Intensive Care COVID-19 group 1
Corresponding author
a Department of Intensive Care Medicine, Critical Care Center, CHU Lille, F-59000 Lille, France
b University of Lille, U995-LIRIC-Lille Inflammation Research International Center, Lille, France
c CHU Lille, Immunology Institute, F-59000 Lille, France
d University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017-CIIL-Centre d’Infection et d’Immunité de Lille, F-59000 Lille, France
e University Lille, Inserm, U1285, CNRS, UMR 8576 - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France
Lille Intensive Care COVID-19 group
Read
2602
Timeswas read the article
1141
Total PDF
1461
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 11 | 74 | 29 | 103 |
| 2025 10 | 7 | 51 | 58 |
| 2025 9 | 0 | 47 | 47 |
| 2025 8 | 0 | 58 | 58 |
| 2025 7 | 0 | 41 | 41 |
| 2025 6 | 1 | 19 | 20 |
| 2025 5 | 94 | 37 | 131 |
| 2025 4 | 66 | 38 | 104 |
| 2025 3 | 75 | 24 | 99 |
| 2025 2 | 79 | 43 | 122 |
| 2025 1 | 62 | 47 | 109 |
| 2024 12 | 67 | 46 | 113 |
| 2024 11 | 50 | 54 | 104 |
| 2024 10 | 67 | 43 | 110 |
| 2024 9 | 55 | 30 | 85 |
| 2024 8 | 62 | 53 | 115 |
| 2024 7 | 67 | 34 | 101 |
| 2024 6 | 62 | 30 | 92 |
| 2024 5 | 54 | 38 | 92 |
| 2024 4 | 54 | 29 | 83 |
| 2024 3 | 61 | 21 | 82 |
| 2024 2 | 49 | 35 | 84 |
| 2024 1 | 52 | 31 | 83 |
| 2023 12 | 28 | 32 | 60 |
| 2023 11 | 42 | 32 | 74 |
| 2023 10 | 37 | 36 | 73 |
| 2023 9 | 27 | 30 | 57 |
| 2023 8 | 24 | 20 | 44 |
| 2023 7 | 32 | 29 | 61 |
| 2023 6 | 29 | 28 | 57 |
| 2023 5 | 43 | 31 | 74 |
| 2023 4 | 38 | 22 | 60 |
| 2023 3 | 2 | 3 | 5 |
| 2023 1 | 1 | 0 | 1 |
Show all
